Shares of Integra Lifesciences IART rose 1.5% in pre-market trading after the company reported Q1 results.
Quarterly Results
Earnings per share increased 43.75% over the past year to $0.69, which beat the estimate of $0.57.
Revenue of $360,071,000 rose by 1.62% from the same period last year, which beat the estimate of $349,810,000.
Guidance
Integra Lifesciences hasn't issued any earnings guidance for the time being.
Revenue guidance hasn't been issued by the company for now.
Conference Call Details
Date: Apr 28, 2021
Time: 08:30 AM
ET Webcast URL: https://www.integralife.com/events
Technicals
Company's 52-week high was at $76.95
52-week low: $42.12
Price action over last quarter: Up 14.00%
Company Profile
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and orthopedics and tissue technologies. Codman specialty surgical generates maximum revenue from its segmental operations. Integra earns approximately 29% of sales internationally, with the remainder 71% derived from the United States.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
